PharmaCielo Ltd. is a Canadian pharmaceutical company focused on cultivating, processing, and supplying all-natural, pharmaceutical-grade medical dried cannabis flower and cannabis extracts to large channel distributors. Its principal subsidiary, PharmaCielo Colombia Holdings S.A.S., operates a cultivation and processing center located in Rionegro, Colombia. PharmaCielo leverages Colombia's favorable geographic conditions to build a sustainable business in the medical cannabis industry.
The company exports its products globally, with its dried flower and cannabis extracts undergoing pre-commercial testing by potential customers in various countries. As of December 2022, PharmaCielo's products were at various stages of testing and sales with customers in 12 countries worldwide. In May 2022, the company partnered with Soteria Holdings Limited to license, import, and wholesale its medical cannabis flower and extracts in the Polish market, one of Europe's largest cannabis markets by patient population. PharmaCielo expected to begin shipping to Poland during the first half of 2023.
In December 2022, PharmaCielo made its first shipment of CBD Isolate to a pharmaceutical company in Morocco, facilitating pre-commercial testing as the customer develops a portfolio of cannabinoid medicines. This marked PharmaCielo's first shipment to Africa, where Morocco is pioneering the commercialization of cannabinoid products.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.